Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.52 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.50 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27324837 | 0.91 | LOXL2 (0.59) | LOXL2DPP4 | |
| SCHEMBL2074734 | 0.91 | LOXL2 (0.59) | LOXL2DPP4 | |
| SCHEMBL12936626 | 0.84 | MTNR1A (0.54) | MTNR1AMTNR1BLOXL2ADAMTS4DPP4 | |
| SCHEMBL29440959 | 0.82 | ALPI (0.54) | MTNR1AMTNR1BLOXL2ADAMTS4DPP4 | |
| SCHEMBL2700469 | 0.82 | ALPI (0.54) | MTNR1AMTNR1BLOXL2ADAMTS4DPP4 | |
| SCHEMBL5159413 | 0.82 | ADAMTS4 (0.54) | MTNR1AMTNR1BLOXL2ADAMTS4KDM4E | |
| SCHEMBL45382 | 0.82 | ALPI (0.54) | MTNR1AMTNR1BLOXL2ADAMTS4DPP4 | |
| SCHEMBL29574121 | 0.82 | ALPI (0.54) | MTNR1AMTNR1BLOXL2ADAMTS4DPP4 | |
| SCHEMBL4393088 | 0.82 | ALPI (0.54) | MTNR1AMTNR1BLOXL2ADAMTS4DPP4 | |
| Acetic Acid SCHEMBL30839816 | 0.80 | MTNR1A (0.59) | MTNR1AMTNR1BLOXL2ADAMTS4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1848412-A2 | TRANSDERMAL SYSTEMS HAVING CONTROL DELIVERY SYSTEM | MYLAN TECHNOLOGIES, INC. (US) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006091442-A2 | TRANSDERMAL SYSTEMS HAVING CONTROL DELIVERY SYSTEM | MYLAN TECHNOLOGIES, INC. (US) | 2006-08-31 | — | — | WO | disclosed |
| WO-2004052336-A2 | HIGH VISCOSITY LIQUID CONTROLLED DELIVERY SYSTEM AND MEDICAL OR SURGICAL DEVICE | DURECT CORPORATION (US) | 2004-06-24 | — | — | WO | disclosed |